See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100412_2016_Array_Biopharma_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001100412, Array Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 191,047,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,050,000 |
| 3 | remainder_Assets | 2,110,000 |
| 4 | LiabilitiesCurrent | 42,424,000 |
| 5 | LiabilitiesNoncurrent | 113,130,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 44,511,730 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,770,789 |
| 9 | ResearchAndDevelopmentExpense | 53,931,650 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 53,540,999 |
| 12 | remainder_NetIncome | -9,619,041 |
| 13 | remainder_ComprehensiveNetIncome | 4,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 198,207,000 |
| 1 | Liabilities | 155,554,000 |
| 2 | Expenses | 130,214,169 |
| 3 | Revenues | 53,540,999 |
| 4 | StockholdersEquity | 42,653,000 |
| 5 | NetIncome | -86,292,211 |
| 6 | ComprehensiveNetIncome | -86,290,211 |
| 7 | BaseVar | 273,569,604 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.0378 |
| 9 | EconomicCapitalRatio | 1.45 |
Edgar->Model Mapping
Feature Distribution
Change over Time
